Saturday 17 October 2026
Export HQY’s income statement to Excel — free account
HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
92.03
0.48
−0.52%
Follow HQY
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
36.06 | 30.49 | 34.97 | 42.80 |
+8 more quarters Free account |
P/S ratio |
6.16 | 5.18 | 5.71 | 6.30 | |
P/FCF ratio |
19.21 | 15.70 | 18.37 | 22.43 | |
P/Operating CF |
61.61 | 71.00 | 63.60 | 58.69 | |
P/B ratio |
4.22 | 3.38 | 3.56 | 3.81 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
6.67 | 5.70 | 6.21 | 6.84 | |
EV/EBITDA |
17.81 | 15.32 | 17.06 | 19.62 | |
EV/Operating CF |
18.53 | 15.55 | 17.84 | 21.27 | |
EV/FCF |
20.80 | 17.28 | 19.97 | 24.33 | |
Quick Ratio |
2.46 | 2.85 | 2.82 | 3.49 | |
Current Ratio |
2.99 | 3.44 | 3.27 | 4.13 | |
Net Debt/EBITDA |
4.79 | 4.80 | 5.80 | 5.71 | |
Debt/Assets |
28.46% | 28.51% | 28.32% | 28.90% | |
Debt/Equity |
0.47 | 0.46 | 0.45 | 0.46 | |
Asset Turnover |
0.41 | 0.40 | 0.38 | 0.37 | |
Operating CF/Net income |
2.07 | 1.40 | 2.37 | 2.68 | |
Capex/Depreciation |
(0.37) | (0.43) | (0.26) | (0.29) | |
Interest Coverage |
7.83 | 8.18 | 5.36 | 5.60 | |
Research and Development Expense of Revenue |
21.08% | 19.11% | 21.03% | 20.46% | |
Selling, General and Administrative Expense of Revenue |
16.56% | 16.34% | 17.47% | 17.16% | |
Intangible Assets out of Total Assets |
0.82 | 0.82 | 0.81 | 0.82 | |
Share Based Compensation of Revenue |
6.33% | 5.47% | 5.71% | 6.38% | |
Graham Net Nets |
(0.10) | (0.11) | (0.10) | (0.09) | |
Graham Number |
38.71 | 38.31 | 37.02 | 35.13 | |
Earnings Yield |
2.77% | 3.28% | 2.86% | 2.34% | |
Free Cash Flow Yield |
5.21% | 6.37% | 5.44% | 4.46% | |
Revenue per Share |
4.21 | 4.20 | 3.88 | 3.75 | |
Operating CF per Share |
1.63 | 1.16 | 1.37 | 1.61 | |
Capex per Share |
(0.19) | (0.19) | (0.12) | (0.13) | |
Free Cash Flow per Share |
1.44 | 0.96 | 1.25 | 1.48 | |
Cash per Share |
3.07 | 3.14 | 3.70 | 3.60 | |
Shareholders Equity per Share |
23.87 | 24.25 | 24.46 | 24.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
23.87 | 24.25 | 24.46 | 24.82 | |
Free Cash Flow |
120.39 | 81.23 | 107.84 | 127.19 | |
Working Capital |
306.43 | 330.79 | 355.43 | 378.08 | |
Capital Expenditures |
(15.77) | (16.29) | (10.07) | (11.38) | |
Net Current Asset Value |
(821.05) | (792.26) | (760.85) | (765.33) | |
EV/EBIT |
25.84 | 22.26 | 25.29 | 30.06 | |
Capex to Sales |
0.05 | 0.05 | 0.03 | 0.04 | |
Price to Operating Income |
23.87 | 20.23 | 23.26 | 27.71 | |
| Other line items | |||||
Average Receivables |
116.68 | 119.13 | 120.85 | 108.98 | |
Average Payables |
9.10 | 13.86 | 13.26 | 14.95 | |
Average Assets |
3,344.02 | 3,361.23 | 3,414.44 | 3,443.20 | |
Average Common Equity |
2,068.27 | 2,085.60 | 2,111.05 | 2,129.36 |
Columns are period end dates